Blurbs

Analysts Offer Insights on Healthcare Companies: Joint (JYNT), 1Life Healthcare (ONEM) and TransMedics Group (TMDX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Joint (JYNTResearch Report), 1Life Healthcare (ONEMResearch Report) and TransMedics Group (TMDXResearch Report).

Joint (JYNT)

In a report issued on February 25, Linda Bolton Weiser from D.A. Davidson maintained a Buy rating on Joint, with a price target of $69.00. The company’s shares closed last Friday at $41.50, close to its 52-week low of $37.42.

According to TipRanks.com, Weiser is a 4-star analyst with an average return of 6.6% and a 52.4% success rate. Weiser covers the Consumer Goods sector, focusing on stocks such as 1-800 Flowers, Helen Of Troy, and Inter Parfums.

Currently, the analyst consensus on Joint is a Moderate Buy with an average price target of $79.50.

See today’s best-performing stocks on TipRanks >>

1Life Healthcare (ONEM)

Morgan Stanley analyst Ricky Goldwasser maintained a Buy rating on 1Life Healthcare on February 24 and set a price target of $14.00. The company’s shares closed last Friday at $10.68, close to its 52-week low of $7.64.

According to TipRanks.com, Goldwasser is a 5-star analyst with an average return of 13.8% and a 65.5% success rate. Goldwasser covers the Healthcare sector, focusing on stocks such as Lifestance Health Group, Bright Health Group, and AmerisourceBergen.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for 1Life Healthcare with a $18.40 average price target, implying an 87.4% upside from current levels. In a report issued on February 24, Evercore ISI also maintained a Buy rating on the stock with a $11.00 price target.

TransMedics Group (TMDX)

Morgan Stanley analyst Cecilia Furlong maintained a Hold rating on TransMedics Group on February 25 and set a price target of $15.00. The company’s shares closed last Friday at $17.07.

According to TipRanks.com, Furlong is a 4-star analyst with an average return of 25.2% and a 61.4% success rate. Furlong covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Edwards Lifesciences, and Irhythm Technologies.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for TransMedics Group with a $27.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on JYNT:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos